European Archives - Page 1083 of 1201 - European Medical Journal

EMJ

EULAR Crowdsources Inspirational Stories to Educate the World about Rheumatic and Musculoskeletal Diseases

Sofia, Bulgaria (15 April 2016): EULAR and the Standing Committee of PARE (People with Arthritis/Rheumatism) has launched ‘The Future In Your Hands’…

EMJ

UK Study Shows Rifaximin-α Significantly Reduces Hospital Resource Use for Patients with Hepatic Encephalopathy

LONDON, UK, Thursday 14 April, 07:00 BST: Norgine B.V. presented new positive UK real world practice data from the IMPRESS retrospective observational…

EMJ

Celyad Will Present Its NKR-2 Immuno-Oncology Clinical Program at 2016 ASCO Annual Meeting

Mont-Saint-Guibert, Belgium: Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a leader in the discovery and development of engineered cell…

EMJ

Patients with EGFR Expressing Non-Small-Cell Lung Cancer Benefit Most from Necitumumab Added to Chemotherapy

GENEVA, Switzerland, 15 April 2016: Patients with epidermal growth factor receptor (EGFR) expressing advanced squamous non-small-cell lung cancer benefit…

EMJ

Immunotherapy with Live Bacterium Improves Response Rate in Malignant Pleural Mesothelioma

GENEVA, Switzerland, 14 April 2016: Immunotherapy with a live bacterium combined with chemotherapy demonstrated more than 90% disease control and…

EMJ

Osimertinib given as First-Line Treatment May Alter Biology of EGFR Mutated Non-Small-Cell Lung Cancer

GENEVA, Switzerland, 14 April 2016 – The third generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) osimertinib is…

EMJ

Richard Wolf Launches a New ENDOCAM Flex HD Video Solution

Knittlingen, 13 April 2016: Manufacturer of medical products Richard Wolf is launching the new “ENDOCAM Flex HD” video solution on 1 March 2016.

EMJ

Discussion on mild and moderate IBD treatment led by Prof Geert D’Haens

Took place during the 11th Congress of ECCO.

EMJ

Success factors in the treatment of uncomplicated CD by Dr Pieter Hindryckx

Took place during the 11th Congress of ECCO. Dr Pieter Hindryckx, Department of Gastroenterology, University Hospital of Ghent, Ghent, Belgium considers…

EMJ

Success factors in the treatment of mild-to-moderate UC by Dr Ailsa Hart

Took place during the 11th Congress of ECCO. During this symposium Dr Ailsa Hart, Director, IBD Unit, St Mark’s Hospital, London, UK discusses the…